Earnings calendar/IDXX
IDEXX LABORATORIES INC /DE (IDXX)
IDEXX LABORATORIES INC /DE (IDXX) Q3 FY2026 (quarter ended ), 10-Q filed (accession 0000874716-26-000135): revenue $1.2B, net income $317.1M, diluted EPS $4.01. Trailing four filed quarters ( to ): revenue $4.7B, diluted EPS $14.84. Figures from the SEC filing, in USD, as reported.
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter IDEXX LABORATORIES INC /DE has filed, from EvidInvest's standardized statements.
Period end
Sep 30, 2026
Q3 FY2026
EPS (diluted)
$4.01
Est. $3.73 · +7.5%
Revenue
$1.21B
Est. $1.19B · +1.9%
Net income
$317.1M
As filed
EPS YoY
+17.9%
vs quarter ended 2025-09-30
Revenue YoY
+9.9%
vs quarter ended 2025-09-30
Next report
Feb 1, 2027
Third-party calendar date, not confirmed by a company filing · est. EPS $3.30
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$14.84
2025-12-31 through 2026-09-30
TTM revenue
$4.66B
2025-12-31 through 2026-09-30
Filed quarters
40
On record here
EPS at or above estimate (4Q)
100%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-09-30Q3 FY2026 | 2026-11-02 | $4.01 | $1.21B | +17.9% | +9.9% | $3.73 | +7.5% |
| 2026-06-30Q2 FY2026 | 2026-08-04 | $4.27 | $1.22B | +17.6% | +9.7% | $3.94 | +8.4% |
| 2026-03-31Q1 FY2026 | 2026-05-05 | $3.47 | $1.14B | +17.2% | +14.3% | $3.41 | +1.8% |
| 2025-12-31Q4 FY2025 | 2026-02-20 | $3.09 | $1.09B | +17.9% | +14.3% | $2.93 | +5.5% |
| 2025-09-30Q3 FY2025 | 2025-11-03 | $3.40 | $1.11B | +21.4% | +13.3% | $3.14 | +8.3% |
| 2025-06-30Q2 FY2025 | 2025-08-04 | $3.63 | $1.11B | +48.8% | +10.6% | $3.28 | +10.7% |
| 2025-03-31Q1 FY2025 | 2025-05-01 | $2.96 | $998.4M | +5.3% | +3.6% | $2.85 | +3.9% |
| 2024-12-31Q4 FY2024 | 2025-02-21 | $2.62 | $954.3M | +13.4% | +5.8% | $2.39 | +9.6% |
| 2024-09-30Q3 FY2024 | 2024-10-31 | $2.80 | $975.5M | +10.7% | +6.6% | $2.68 | +4.5% |
| 2024-06-30Q2 FY2024 | 2024-08-06 | $2.44 | $1.00B | -8.6% | +6.4% | $2.88 | -15.3% |
| 2024-03-31Q1 FY2024 | 2024-05-01 | $2.81 | $964.1M | +10.2% | +7.1% | $2.67 | +5.2% |
| 2023-12-31Q4 FY2023 | 2024-02-22 | $2.31 | $901.6M | +12.7% | +8.8% | $2.12 | +9.0% |
| 2023-09-30Q3 FY2023 | 2023-11-01 | $2.53 | $915.5M | +17.7% | +8.8% | $2.37 | +6.8% |
| 2023-06-30Q2 FY2023 | 2023-08-01 | $2.67 | $943.6M | +71.2% | +9.7% | $2.47 | +8.1% |
| 2023-03-31Q1 FY2023 | 2023-05-02 | $2.55 | $900.2M | +12.3% | +7.6% | $2.42 | +5.4% |
| 2022-12-31Q4 FY2022 | 2023-02-16 | $2.05 | $828.6M | +9.0% | +3.4% | $1.94 | +5.7% |
| 2022-09-30Q3 FY2022 | 2022-11-01 | $2.15 | $841.7M | +5.9% | +3.9% | $2.04 | +5.4% |
| 2022-06-30Q2 FY2022 | 2022-08-02 | $1.56 | $860.5M | -33.3% | +4.2% | $1.56 | 0.0% |
| 2022-03-31Q1 FY2022 | 2022-05-04 | $2.27 | $836.5M | -3.4% | +7.6% | — | — |
| 2021-12-31Q4 FY2021 | 2022-02-16 | $1.88 | $801.1M | -6.5% | +11.1% | — | — |
| 2021-09-30Q3 FY2021 | 2021-11-02 | $2.03 | $810.4M | +20.1% | +12.3% | — | — |
| 2021-06-30Q2 FY2021 | 2021-07-30 | $2.34 | $826.1M | +36.0% | +29.6% | — | — |
| 2021-03-31Q1 FY2021 | 2021-05-04 | $2.35 | $777.7M | +82.2% | +24.2% | — | — |
| 2020-12-31Q4 FY2020 | 2021-02-12 | $2.01 | $720.9M | +93.3% | +19.1% | — | — |
| 2020-09-30Q3 FY2020 | 2020-10-29 | $1.69 | $721.8M | +36.3% | +19.2% | — | — |
| 2020-06-30Q2 FY2020 | 2020-07-31 | $1.72 | $637.6M | +20.3% | +2.8% | — | — |
| 2020-03-31Q1 FY2020 | 2020-04-30 | $1.29 | $626.3M | +10.3% | +8.7% | — | — |
| 2019-12-31Q4 FY2019 | 2020-02-14 | $1.04 | $605.4M | +6.1% | +10.2% | — | — |
| 2019-09-30Q3 FY2019 | 2019-10-31 | $1.24 | $605.3M | +18.1% | +11.0% | — | — |
| 2019-06-30Q2 FY2019 | 2019-08-01 | $1.43 | $620.1M | +16.3% | +6.8% | — | — |
| 2019-03-31Q1 FY2019 | 2019-05-01 | $1.17 | $576.1M | +15.8% | +7.1% | — | — |
| 2018-12-31Q4 FY2018 | 2019-02-15 | $0.98 | $549.4M | +127.9% | +8.5% | — | — |
| 2018-09-30Q3 FY2018 | 2018-11-01 | $1.05 | $545.4M | +32.9% | +10.9% | — | — |
| 2018-06-30Q2 FY2018 | 2018-08-01 | $1.23 | $580.8M | +29.5% | +14.1% | — | — |
| 2018-03-31Q1 FY2018 | 2018-05-04 | $1.01 | $537.7M | +31.2% | +16.4% | — | — |
| 2017-12-31Q4 FY2017 | 2018-02-16 | $0.43 | $506.1M | -25.9% | +14.2% | — | — |
| 2017-09-30Q3 FY2017 | 2017-10-31 | $0.79 | $492.0M | — | — | — | — |
| 2017-06-30Q2 FY2017 | 2017-08-01 | $0.95 | $508.9M | — | — | — | — |
| 2017-03-31Q1 FY2017 | 2017-04-28 | $0.77 | $462.0M | — | — | — | — |
| 2016-12-31Q4 FY2016 | 2017-02-17 | $0.58 | $443.0M | — | — | — | — |
Need IDXX data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.